Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 8Gynecologic 5Breast 5Tumor-Agnostic 4Thoracic 3Other solid neoplasm 3Genitourinary 3Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1

Conditions

Neoplasms 3Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Telemedicine × Tumor-Agnostic × Clear all
NCT07069868 2025-07-17

Telehealth in an Ambulatory Oncology Phase I Clinical Trial Unit

Massachusetts General Hospital

Phase NA Completed
21 enrolled
Tumor-Agnostic

Neoplasms

NCT02751580 2025-05-16

Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy Visits

Thomas Jefferson University

Phase NA Completed
37 enrolled 12 charts
Tumor-Agnostic

Neoplasms

NCT04697524 2023-08-15

Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer

University of California, San Francisco

Phase NA Completed
30 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT02238951 2018-11-16

4CP

University of California, Davis

Phase NA Completed
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡